Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
117K
-
Shares change
-
-17.4K
-
Total reported value, excl. options
-
$338K
-
Value change
-
-$56.5K
-
Number of buys
-
6
-
Number of sells
-
-3
-
Price
-
$2.89
Significant Holders of ARTELO BIOSCIENCES, INC. - COM (ARTL) as of Q4 2022
9 filings reported holding ARTL - ARTELO BIOSCIENCES, INC. - COM as of Q4 2022.
ARTELO BIOSCIENCES, INC. - COM (ARTL) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117K shares
.
Largest 9 shareholders include VANGUARD GROUP INC (62.6K shares), TWO SIGMA ADVISERS, LP (36K shares), GEODE CAPITAL MANAGEMENT, LLC (13.7K shares), UBS Group AG (3.05K shares), Tower Research Capital LLC (TRC) (1.63K shares), CREATIVE FINANCIAL DESIGNS INC /ADV (72 shares), MORGAN STANLEY (25 shares), WELLS FARGO & COMPANY/MN (18 shares), and TWO SIGMA INVESTMENTS, LP (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.